Goldstein; Gideon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Goldstein; Gideon.The latest application filed is for "compositions for selective reduction of circulating bioactive soluble tnf and methods for treating tnf-mediated disease".

Company Profile

0.43.15

Goldstein; Gideon - New York NY
Goldstein; Gideon - Short Hills NJ
Goldstein; Gideon - Riverdale NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions For Selective Reduction Of Circulating Bioactive Soluble Tnf And Methods For Treating Tnf-mediated Disease App 20170190768 - Goldstein; Gideon	2017-07-06
Compositions for selective reduction of circulating bioactive soluble TNF and methods for treating TNF-mediated disease Grant 9,580,502 - Goldstein February 28, 2	2017-02-28
Compositions For Selective Reduction Of Circulating Bioactive Soluble Tnf And Methods For Treating Tnf-mediated Disease App 20160272705 - Goldstein; Gideon	2016-09-22
Compositions for selective reduction of circulating bioactive soluble TNF and methods for treating TNF-mediated disease Grant 9,388,240 - Goldstein July 12, 2	2016-07-12
Immunogenic and Prophylactic Compositions, Methods of Making Same, and Methods for Treating and Preventing TNF-Mediated Disease App 20150225478 - Goldstein; Gideon	2015-08-13
Compositions for Selective Reduction of Circulating Bioactive Soluble TNF and Methods for Treating TNF-Mediated Disease App 20150225477 - Goldstein; Gideon	2015-08-13
Compositions and Methods for the Treatment and Prophylaxis of Multiple Strains and Subtypes of HIV-1 App 20110189216 - Goldstein; Gideon	2011-08-04
Compositions and methods for the treatment and prophylaxis of multiple strains and subtypes of HIV-1 Grant 7,943,140 - Goldstein May 17, 2	2011-05-17
Methods and compositions for impairing multiplication of HIV-1 Grant 7,563,437 - Carlsson , et al. July 21, 2	2009-07-21
Compositions and methods for the treatment and prophylaxis of Alzheimer's disease App 20090123488 - Goldstein; Gideon	2009-05-14
Compositions and methods for the treatment and prophylaxis of multiple strains and subtypes of HIV-1 App 20090092626 - Goldstein; Gideon	2009-04-09
Assays for Detecting Hiv-1 Tat Protein in Hiv-1 Infection App 20080280305 - Goldstein; Gideon	2008-11-13
Methods and compositions for impairing multiplication of HIV-1 App 20060258594 - Goldstein; Gideon	2006-11-16
Methods and compositions for impairing multiplication of HIV-1 App 20060211108 - Carlsson; Roland ; et al.	2006-09-21
Methods and compositions for impairing multiplication of HIV-1 Grant 7,008,622 - Goldstein March 7, 2	2006-03-07
Methods and compositions for impairing multiplication of HIV-1 App 20050245454 - Goldstein, Gideon	2005-11-03
Methods and compositions for impairing multiplication of HIV-1 App 20030194408 - Goldstein, Gideon	2003-10-16
Methods and compositions for impairing multiplication of HIV-1 App 20030180326 - Goldstein, Gideon	2003-09-25
Methods and compositions for impairing multiplication of HIV-1 App 20030166832 - Goldstein, Gideon	2003-09-04
Methods and compositions for impairing multiplication of HIV-1 Grant 6,524,582 - Goldstein February 25, 2	2003-02-25
Methods and compositions for impairing multiplication of HIV-1 App 20020192232 - Goldstein, Gideon	2002-12-19
Tetra and penta-peptides useful in regulating the immune system Grant 5,298,490 - Heavner , et al. March 29, 1	1994-03-29
B cell differentiating peptides and conjugates thereof Grant 4,866,121 - Audhya , et al. * September 12, 1	1989-09-12
B-cell differentiating peptides Grant 4,783,442 - Audhya , et al. * November 8, 1	1988-11-08
Treatment of allergy with thymopentin Grant 4,749,690 - Goldstein June 7, 1	1988-06-07
Monoclonal antibody therapy Grant 4,731,244 - Talle , et al. March 15, 1	1988-03-15
Complement-fixing monoclonal antibody to human T cells Grant 4,658,019 - Kung , et al. * April 14, 1	1987-04-14
Monoclonal antibody to human helper T cells Grant 4,658,020 - Kung , et al. * April 14, 1	1987-04-14
Methods and compositions using monoclonal antibody to human T cells Grant 4,657,760 - Kung , et al. * April 14, 1	1987-04-14
Methods and compositions using complement fixing monoclonal antibody to human T cells Grant 4,654,210 - Kung , et al. March 31, 1	1987-03-31
Methods and compositions using monoclonal antibody to human helper T cells Grant 4,652,447 - Kung , et al. March 24, 1	1987-03-24
Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigens, antibody, and methods Grant 4,624,925 - Kung , et al. November 25, 1	1986-11-25
Hybrid cell line for producing monoclonal antibody to a human T cell antigen, antibody, and methods Grant 4,614,720 - Kung , et al. September 30, 1	1986-09-30
Conformationally restricted thymopentin-like compounds Grant 4,547,489 - Goldstein , et al. October 15, 1	1985-10-15
Hybrid cell line for producing monoclonal antibody to human T cells Grant 4,515,894 - Kung , et al. * May 7, 1	1985-05-07
Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells Grant 4,515,893 - Kung , et al. * May 7, 1	1985-05-07
Enzyme-resistant immunomodulatory peptides Grant 4,505,853 - Goldstein , et al. March 19, 1	1985-03-19
Peptides having thymopoietin-like activity Grant 4,397,842 - Goldstein , et al. August 9, 1	1983-08-09
Monoclonal antibody to human helper T cells and methods of preparing same Grant 4,381,295 - Kung , et al. April 26, 1	1983-04-26
Monoclonal antibody to a human T cell antigen and methods of preparing same Grant 4,364,937 - Kung , et al. December 21, 1	1982-12-21
Monoclonal antibody to a human early thymocyte antigen and methods for preparing same Grant 4,364,934 - Kung , et al. December 21, 1	1982-12-21
Monoclonal antibody to a human prothymocyte antigen and methods of preparing same Grant 4,364,935 - Kung , et al. December 21, 1	1982-12-21
Monoclonal antibody to human cytotoxic and suppressor T cells and methods of preparing same Grant 4,364,932 - Kung , et al. December 21, 1	1982-12-21
Monoclonal antibody to a human thymocyte antigen and methods of preparing same Grant 4,364,933 - Kung , et al. December 21, 1	1982-12-21
Monoclonal antibody to a human monocyte antigen and methods of preparing same Grant 4,364,936 - Kung , et al. December 21, 1	1982-12-21
Monoclonal antibody to human T cells, and methods for preparing same Grant 4,363,799 - Kung , et al. December 14, 1	1982-12-14
Complement-fixing monoclonal antibody to human T cells, and methods of preparing same Grant 4,361,549 - Kung , et al. November 30, 1	1982-11-30
Complement-fixing monoclonal antibody to human suppressor T cells and methods of preparing same Grant 4,361,550 - Kung , et al. November 30, 1	1982-11-30
Immunoregulatory diketopiperazine compounds Grant 4,289,759 - Heavner , et al. September 15, 1	1981-09-15
Pentapeptide modified resin Grant 4,258,151 - Goldstein , et al. March 24, 1	1981-03-24
Peptides having ubiquitin-like activity Grant 4,215,111 - Goldstein , et al. July 29, 1	1980-07-29
Polypeptides and methods Grant 4,190,647 - Goldstein , et al. February 26, 1	1980-02-26
Polypeptide compositions and methods Grant 4,190,646 - Goldstein , et al. February 26, 1	1980-02-26
Ubiquitous immunopoietic polypeptide (UBIP) and methods Grant 4,167,557 - Goldstein * September 11, 1	1979-09-11
Polypeptide hormones of the thymus Grant 4,120,951 - Goldstein October 17, 1	1978-10-17
Polypeptide hormones of the thymus Grant 4,077,949 - Goldstein March 7, 1	1978-03-07
Immunoassay for thymopoietin Grant 4,055,633 - Goldstein October 25, 1	1977-10-25
Tridecapeptide compositions and methods Grant 4,002,740 - Goldstein , et al. January 11, 1	1977-01-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.